Weiss L, Stintzing S, Stahler A, Benedikt Westphalen C, et al. Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild-type metastatic colorectal cancer. Eur J Cancer 2025;221:115399.
PMID: 40222201